The Effect of a TLR3 Agonist on Airway Allergic Inflammation and Viral Infection in Immunoproteasome-Deficient Mice
Viruses · 2024
DOI: 10.3390/v16091384 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Niccolette Schaunaman und 5 weiteren Autor:innen. Beteiligte Einrichtung: National Jewish Health, Denver, CO 80206, USA. Hauptthemen laut MEDLINE: Toll-Like Receptor 3, Mice, Knockout, Proteasome Endopeptidase Complex, Rhinovirus. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, NIH grants.
Abstract (Originalsprache)
Allergic asthma is characterized by increased type 2 inflammation, including eosinophils. Subjects with allergic asthma have recurrent symptoms due to their constant exposure to environmental allergens, such as house dust mite (HDM), which can be further exacerbated by respiratory infections like rhinovirus. The immunoproteasome (IP) is a proteolytic machinery that is induced by inflammatory mediators during virus infection, but the role of the IP in airway allergic inflammation during rhinovirus infection remains unknown. Wild-type (WT) and IP knockout (KO) mice were challenged with HDM. At 48 h after the last HDM challenge, mice were infected with rhinovirus 1B (RV-A1B) for 24 h. After HDM and RV-A1B treatment, IP KO (vs. WT) mice had significantly more lung eosinophils and neutrophils, as well as a significantly higher viral load, but less IFN-beta expression, compared to WT mice. A TLR3 agonist polyinosinic-polycytidylic acid (Poly I:C) treatment after RV-A1B infection in HDM-challenged IP KO mice significantly increased IFN-beta expression and reduced viral load, with a minimal effect on the number of inflammatory cells. Our data suggest that immunoproteasome is an important mechanism functioning to prevent excessive inflammation and viral infection in allergen-exposed mice, and that Poly I:C could be therapeutically effective in enhancing the antiviral response and lessening the viral burden in lungs with IP deficiency.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Jewish Health, Denver, CO 80206, USA.
- Doheny Eye Institute, University of California Los Angeles, Arcadia, CA 91007, USA.
Förderung
- NIAID NIH HHS
- NIH HHS
- NIH grants
Zitieren
APA
Schaunaman, N., Nichols, T., Cervantes, D., Hartsoe, P., Ferrington, D. A., & Chu, H. W. (2024). The Effect of a TLR3 Agonist on Airway Allergic Inflammation and Viral Infection in Immunoproteasome-Deficient Mice. Viruses. https://doi.org/10.3390/v16091384
Vancouver
Schaunaman N, Nichols T, Cervantes D, Hartsoe P, Ferrington DA, Chu HW. The Effect of a TLR3 Agonist on Airway Allergic Inflammation and Viral Infection in Immunoproteasome-Deficient Mice. Viruses. 2024. doi:10.3390/v16091384
BibTeX
@article{Schaunaman2024,
author = {Schaunaman, Niccolette and Nichols, Taylor and Cervantes, Diana and Hartsoe, Paige and Ferrington, Deborah A and Chu, Hong Wei},
title = {The Effect of a TLR3 Agonist on Airway Allergic Inflammation and Viral Infection in Immunoproteasome-Deficient Mice},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16091384}
}
EUVIMED